Drug price reform will 'improve services'
Updated: 2016-07-07 07:51
By Wang Yanfei(China Daily)
|
|||||||||
Patients receive treatment at a Traditional Chinese Medicine hospital in Dongguang county, Hebei province, in June. Fu Xinchun / For China Daily |
China's top pricing regulator launched a new round of drug pricing and healthcare financing reform on Wednesday in the latest attempt to improve the nation's public healthcare system.
The pricing reform is expected by the end of 2020, by which time financing of all public hospitals will mainly depend on healthcare services and government compensation, rather than markups of drug prices, according to a guideline issued by the National Development and Reform Commission.
"The 15 percent markup that hospitals add on drug prices will no longer be a way to finance public hospitals," said Zhu Dezheng, head of the commission's drug pricing division.
Zhu said reduced income from the markups will be balanced by raising prices for basic healthcare services, such as nursing care.
A total of 200 pilot cities will cancel the drug price markups by the end of this year, according to the National Health and Family Planning Commission.
"Markups on drug pricing used to be a reasonable track for hospitals to generate income in the past because of low public funding, but it has become a skewed incentive that increases the cost for patients. Hospitals tend to prescribe expensive drugs," said Zhu.
Some hospitals receive more than 40 percent of their income from drug price markups, he said.
"The zero markup will provide a positive incentive for hospitals to improve healthcare services and upgrade treatment technologies," he said.
Hospitals will have more freedom to adjust the prices of healthcare services in the future, as the commission pledged to gradually narrow the scope of government-mandated pricing.
While addressing the impact of the reform on patients, Zhang Ziling, an official at the Human Resources and Social Security Department in Jiangsu province, said patients who rely mainly on prescriptions will benefit more from the pricing reform than those who require services such as surgery.
"The overall level of medical expenses levied on patients is not expected to increase," said Zhang.
The nation has been pressing ahead with healthcare reform, and the pricing scheme for healthcare services and drugs are among the key tasks, Premier Li Keqiang stressed during a State Council meeting earlier this year.
Today's Top News
Chilcot report: Iraq war based on flawed intelligence
UK invasion of Iraq was not last resort: Report
Berlusconi accepts Chinese offer for AC Milan
UK consultancy loses license, Chinese graduates being told to leave
Chinese online retailers offer 'Brexit sales' as sterling hits record lows
British PM race cut to 3 hopefuls
Suicide bombers hit three Saudi cities
Response to 'fully depend' on Manila
Hot Topics
Lunar probe , China growth forecasts, Emission rules get tougher, China seen through 'colored lens', International board,
Editor's Picks
Hollywood snaps up rock star's dog film |
Chinese people welcome dispossessed |
The can-do generation to the fore |
Riding the wave |
Leisure giants buoy cruise market |
She followed her heart |